Latest Insider Transactions at Rhythm Pharmaceuticals, Inc. (RYTM)
This section provides a real-time view of insider transactions for Rhythm Pharmaceuticals, Inc. (RYTM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of RHYTHM PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of RHYTHM PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2020
|
Ra Capital Management, L.P. |
SELL
Open market or private sale
|
Indirect |
61,901
-1.17%
|
$1,361,822
$22.15 P/Share
|
|
Jun 29
2020
|
Ra Capital Management, L.P. |
SELL
Open market or private sale
|
Indirect |
52,049
-0.98%
|
$1,145,078
$22.19 P/Share
|
|
Jun 26
2020
|
Ra Capital Management, L.P. |
SELL
Open market or private sale
|
Indirect |
86,706
-1.6%
|
$1,994,238
$23.31 P/Share
|
|
Jun 25
2020
|
Ra Capital Management, L.P. |
SELL
Open market or private sale
|
Indirect |
11,568
-0.21%
|
$289,200
$25.05 P/Share
|
|
May 22
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,580
-0.35%
|
$587,400
$30.67 P/Share
|
|
May 21
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
62,500
-2.21%
|
$1,937,500
$31.01 P/Share
|
|
May 18
2018
|
Orbimed Advisors LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
69,136
-2.38%
|
$2,074,080
$30.77 P/Share
|
|
Oct 10
2017
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
355,000
+10.9%
|
$6,035,000
$17.0 P/Share
|
|
Oct 10
2017
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
2,546,295
+50.0%
|
-
|
|
Oct 10
2017
|
James E Flynn > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
355,000
+27.48%
|
$6,035,000
$17.0 P/Share
|
|
Oct 10
2017
|
James E Flynn > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
582,010
+50.0%
|
-
|
|
Oct 05
2017
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
885,000
+31.88%
|
$15,045,000
$17.0 P/Share
|
|
Oct 05
2017
|
Baker Bros. Advisors LP |
BUY
Conversion of derivative security
|
Indirect |
1,164,020
+50.0%
|
-
|